arrow
N

Naohiro Yonemoto

University of Toyama
H指数:134
被引数:28.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical failure in bloodstream infections extends beyond antimicrobial therapy: Factors associated with individual outcomes in a multicenter prospective cohort study

血流感染中的临床失败超出抗菌治疗范围:一项多中心前瞻性队列研究中与个体结局相关的因素

2026-11-040
PRE
Cluster-randomized evaluation of neonatal intensive care unit quality improvement interventions in extremely preterm infants: secondary analysis of the INTACT trial

极早产儿重症监护病房质量改进干预措施的整群随机评估:INTACT试验的二次分析

2026-01-050
OA
Corrigendum to “Neurological prognosis prediction upon arrival at the hospital after out-of-hospital cardiac arrest: R-EDByUS score”. [Resuscitation 200 (2024) 110257]

勘误:“院外心脏骤停后入院时的神经预后预测:R-EDByUS评分”。[《心肺复苏》200 (2024) 110257]

2025-11-140
OAAI
Effects of paroxetine, a P2X4 inhibitor, on cerebral aneurysm growth and recanalization after coil embolization: the NHO Drug for Aneurysm Study
2024-10-010
PRE
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021

全球、区域和国家在实现世卫组织终结结核病战略的2020里程碑方面取得的进展: 对全球疾病负担研究2021的系统分析

2024-07-0111
OAAI
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

1950至2021 204个国家和地区的全球生育率,预测到2100: 全球疾病负担研究2021的综合人口分析

LANCET
IF88.5
2024-05-0143
OAAI